Robert B. Jenkins
About
In The Last Decade
Robert B. Jenkins
28 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 504
- Pulmonary and Respiratory Medicine 455
- Genetics 356
- Cancer Research 330
- Oncology 272
Countries citing papers authored by Robert B. Jenkins
This map shows the geographic impact of Robert B. Jenkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Jenkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Jenkins more than expected).
Fields of papers citing papers by Robert B. Jenkins
This network shows the impact of papers produced by Robert B. Jenkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Jenkins. The network helps show where Robert B. Jenkins may publish in the future.
Co-authorship network of co-authors of Robert B. Jenkins
This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Jenkins. A scholar is included among the top collaborators of Robert B. Jenkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Jenkins. Robert B. Jenkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 148 | |
| 2 | 58 | |
| 3 | 40 | |
| 4 | 7 | |
| 5 | 89 | |
| 6 | 91 | |
| 7 | 10 | |
| 8 | Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridol. | 43 |
| 9 | 6 | |
| 10 | 16 | |
| 11 | 9 | |
| 12 | 22 | |
| 13 | Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. | 116 |
| 14 | 13 | |
| 15 | 71 | |
| 16 | 14 | |
| 17 | 71 | |
| 18 | 17 | |
| 19 | 42 | |
| 20 | 87 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.